Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Varicella-zoster virus recapitulates its immune evasive behaviour in matured hiPSC-derived neurospheroids
Authors:ID Govaerts, Jonas (Author)
ID Van Breedam, Elise (Author)
ID Motaln, Helena, Institut "Jožef Stefan" (Author)
ID Rogelj, Boris (Author)
ID Ponsaerts, Peter (Author)
Files:URL URL - Source URL, visit https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1458967/full
 
.pdf PDF - Presentation file, download (12,62 MB)
MD5: 6F762187F62C8C9389805B6D77E69FAC
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Varicella-zoster virus (VZV) encephalitis and meningitis are potential central nervous system (CNS) complications following primary VZV infection or reactivation. With Type-I interferon (IFN) signalling being an important first line cellular defence mechanism against VZV infection by the peripheral tissues, we here investigated the triggering of innate immune responses in a human neural-like environment. For this, we established and characterised 5-month matured hiPSC-derived neurospheroids (NSPHs) containing neurons and astrocytes. Subsequently, NSPHs were infected with reporter strains of VZV (VZVeGFP-ORF23) or Sendai virus (SeVeGFP), with the latter serving as an immune-activating positive control. Live cell and immunocytochemical analyses demonstrated VZVeGFP-ORF23 infection throughout the NSPHs, while SeVeGFP infection was limited to the outer NSPH border. Next, NanoString digital transcriptomics revealed that SeVeGFP-infected NSPHs activated a clear Type-I IFN response, while this was not the case in VZVeGFP-ORF23-infected NSPHs. Moreover, the latter displayed a strong suppression of genes related to IFN signalling and antigen presentation, as further demonstrated by suppression of IL-6 and CXCL10 production, failure to upregulate Type-I IFN activated anti-viral proteins (Mx1, IFIT2 and ISG15), as well as reduced expression of CD74, a key-protein in the MHC class II antigen presentation pathway. Finally, even though VZVeGFP-ORF23-infection seems to be immunologically ignored in NSPHs, its presence does result in the formation of stress granules upon long-term infection, as well as disruption of cellular integrity within the infected NSPHs. Concluding, in this study we demonstrate that 5-month matured hiPSC-derived NSPHs display functional innate immune reactivity towards SeV infection, and have the capacity to recapitulate the strong immune evasive behaviour towards VZV.
Keywords:interferon signalling, neurospheroids, antigen presentation, stress granules, structural integrity
Publication status:Published
Publication version:Version of Record
Submitted for review:03.07.2024
Article acceptance date:13.08.2024
Publication date:16.09.2024
Publisher:Frontiers
Year of publishing:2024
Number of pages:str. 1-19
Numbering:Vol 15
Source:Švica
PID:20.500.12556/DiRROS-21153 New window
UDC:57
ISSN on article:1664-3224
DOI:10.3389/fimmu.2024.1458967 New window
COBISS.SI-ID:207650563 New window
Copyright:© 2024 Govaerts, Van Breedam, De Beuckeleer, Goethals, D’Incal, Di Stefano, Van Calster, Buyle-Huybrecht, Boeren, De Reu, Paludan, Thiry, Lebrun, Sadzot-Delvaux, Motaln, Rogelj, Van Weyenbergh, De Vos, Vanden Berghe, Ogunjimi, Delputte and Ponsaerts.
Note:Nasl. z nasl. zaslona; Soavtorja iz Slovenije: Helena Motaln, Boris Rogelj; Opis vira z dne 16. 9. 2024;
Publication date in DiRROS:08.01.2025
Views:26
Downloads:10
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in immunology
Shortened title:Front. immunol.
Publisher:Frontiers Research Foundation
ISSN:1664-3224
COBISS.SI-ID:30774233 New window

Document is financed by a project

Funder:Other - Other funder or multiple funders
Project number:G034721N

Funder:Other - Other funder or multiple funders
Project number:I000123N

Funder:Other - Other funder or multiple funders
Project number:I003420N

Funder:Other - Other funder or multiple funders
Project number:1861219N

Funder:Other - Other funder or multiple funders
Project number:K800224N

Funder:Other - Other funder or multiple funders
Project number:V511123N

Funder:Other - Other funder or multiple funders
Funding programme:M-ERA-NET program
Project number:M-ERA-NET3/0007/2021

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4503
Name:Nepravilnosti v translaciji, ki so podlaga za amiotrofično lateralno sklerozo in frontotemporalno demenco povezano z mutacijo v genu C9orf72

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-3065
Name:Ciljanje faznega ločevanja in agregacije proteinov v nevrodegenerativnih proteinopatijah TDP-43

Funder:Other - Other funder or multiple funders
Project number:UA BOF-GOA 2020

Funder:Other - Other funder or multiple funders
Project number:UA BOF-SEP 2022

Funder:Other - Other funder or multiple funders
Project number:BOF IOF FFI210239

Funder:Other - Other funder or multiple funders
Project number:813263

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:16.09.2024
Applies to:VoR

Back